NEWSROOM

STAY CONNECTED with our latest news

You are here: / NEWSROOM

NEWS

ENHPATHY highlighted in the Winter issue of EU Research

Studying enhancer function to understand human disease Enhancers play an important role in determining how genes are expressed in different cells in the body. The goal of the ENHPATHY consortium is to identify these enhancers…

Pitch my Enhancer in art project in 90 seconds

On June 15th, our 15 students will face the challenge of presenting their Enhancer in art project to a lay audience. One condition: not to exceed 90 seconds!   Register to watch the presentations live on Youtube.   About Enhancer…

Current challenges in understanding the role of enhancers in disease

Enhancers play a central role in the spatiotemporal control of gene expression and tend to work in a cell-type-specific manner. In addition, they are suggested to be major contributors to phenotypic variation, evolution and disease. There…

Chronic inflammation decreases HSC fitness by activating the druggable Jak/Stat3 signaling pathway

New publication by Alberich-Jorda M and Sladana Kosanovic in EMBO reports. Chronic inflammation represents a major threat to human health since long-term systemic inflammation is known to affect distinct tissues and organs. Recently, solid…

ENHPATHY ESRs visit the Novartis Institutes for BioMedical Research (NIBR)

The Novartis Institutes for BioMedical Research (NIBR) is the innovation engine of Novartis. NIBR's Scientists collaborate across scientific and organizational boundaries, with a focus on powerful new technologies that have the potential…

Epromoters: The regulation of gene expression is no longer a binary issue

In all mammals, the cellular operation responsible for the maintenance of homeostasis, specifically of all the physiological balances ensuring the vital functions of an organism, is dictated by the reading of information carefully preserved…

The EMBO workshop starts today

The new  EMBO workshop co-organized by Álvaro Rada-Iglesias, Salvatore Spicuglia and Susanne Mandrup and involving 6 Enhpathy's students starts today. Please find more information about this event on the EMBO Workshop's website. About…

1 PhD position available, join the ENHPATHY Innovative Training Network today!

One position is available for a 2-year PhD program funded by the Marie Sklodowska-Curie Innovative Training Network (ITN) ENHPATHY. Candidates with bioinformatics, genomics and/or molecular and cellular biology backgrounds are encouraged…

EMBO workshop, October 6-9, 2021 | Santander Spain

The new  EMBO workshop co-organized by Álvaro Rada-Iglesias, Salvatore Spicuglia and Susanne Mandrup is now open for registration –> register here.  About the Workshop Due to the current COVID-19 emergency this workshop…

Kickoff meeting …checked! Enhpathy officially launched its program.

ENHPATHY is a multidisciplinary science consortium created in the frame of the Marie Sklodowska-Curie actions (MSCA)-ITN-ETN European Training Networks call and regrouping 12 academic and 3 non-academic European organisations in the continuum…

The (MSCA)-ITN the Innovative Training Networks program ENHPATHY to be launched on March 01, 2020

We are pleased to announce that the EnhPathy ITN H2020 PhD call will open on March 15th 2020. EnhPathy will be recruiting 15 PhD students to start their training program within the September-December 2020 period. Please check the Nature…

EMBO workshop, May 25-28 2020, Santander Spain (Rescheduled)

The new  EMBO workshop co-organized by Álvaro Rada-Iglesias, Salvatore Spicuglia and Susanne Mandrup is now open for registration –> https://bit.ly/2qoO4yC  About the workshop : Mutations…

ENHPATHY 1ST MEETING – NOV 6TH 2018, MARSEILLE FRANCE

Brainstorming meeting gathering Enhpathy members - Marseille. List of beneficiaries : Salvatore Spicuglia (Coordinator), Institut Nationale pour la Santé et la Recherche Médicale (INSERM), France Alvaro Rada-Iglesias (Vice Coordinator),…

QUESTION ABOUT ENHPATHY?

LET’S TALK!

Marie CurieThis project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 860002. The information contained in this website reflects only the authors’ view. REA and EC are not responsible for any use that may be made of this information.